Latham Recognized With Two Awards From LMG Life Sciences
Firm awarded for excellence and innovation in the life science legal space.
Elizabeth Richards, a partner in the Healthcare & Life Sciences Practice, focuses her practice advising clients on matters involving oversight and regulation by the US Food and Drug Administration (FDA).
Ms. Richards helps clients navigate regulatory, compliance, transactional, and legislative matters involving the FDA. She also counsels clients on matters involving regulation by the Drug Enforcement Administration (DEA). Her practice spans all stages of the product life cycle, including with respect to:
Ms. Richards regularly counsels clients in the food, dietary supplement, pharmaceutical, medical device, digital health, cosmetic, and other life sciences and biotechnology industries on regulatory compliance and enforcement matters. With the enactment of the Farm Bill in 2018, she also represents companies seeking to market CBD products to navigate the evolving legal framework governing the industry.
Ms. Richards frequently drafts and negotiates contracts with clinical trial sites, contract research organizations, contract manufacturers and laboratories, and other vendors on behalf of pharmaceutical and medical device company clients. She also regularly advises on regulatory matters in connection with capital markets, financing, and M&A transactions involving FDA- and DEA-regulated entities.
Ms. Richards regularly writes and speaks on technical FDA regulatory and enforcement matters, including as part of the Latham Healthcare and Life Sciences Hot Topics video series, the Connected With Latham Health Tech podcast series, and at Food and Drug Law Institute (FDLI)-sponsored events.
She currently serves as a member of the FDLI’s Medical Products Committee and 2023 Digital Health Committee, and has previously served on its Publications and Academic Programs Committee. Ms. Richards is also a member of Latham’s Artificial Intelligence Task Force, bringing together subject matter experts tracking developments in the rapidly evolving digital health space, and she participates in the Medical Device Manufacturers Association’s FDA Working Group. Ms. Richards also previously served as an Advisory Board member of the Children’s Law Center.
Firm awarded for excellence and innovation in the life science legal space.
Partners Brenda Danek, Inge Osman, and Elizabeth Richards named “Women Worth Watching in STEM 2020.”
Partner Elizabeth Richards talks about closing the STEM gender gap, moving women forward in STEM, and why a STEM career.